These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

853 related articles for article (PubMed ID: 24398173)

  • 21. Genome-wide microarray analysis identifies a potential role for striatal retrograde endocannabinoid signaling in the pathogenesis of experimental L-DOPA-induced dyskinesia.
    Wang Y; Zhang QJ; Wang HS; Wang T; Liu J
    Synapse; 2014 Aug; 68(8):332-43. PubMed ID: 24599755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphological dendritic spine changes of medium spiny neurons in the nucleus accumbens in 6-hydroxydopamine-lesioned rats treated with levodopa.
    Funamizu Y; Nishijima H; Ueno T; Ueno S; Mizukami H; Yagihashi S; Tomiyama M
    Neurosci Res; 2017 Aug; 121():49-53. PubMed ID: 28392304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A positive allosteric modulator of mGlu4 receptors restores striatal plasticity in an animal model of l-Dopa-induced dyskinesia.
    Calabrese V; Picconi B; Heck N; Campanelli F; Natale G; Marino G; Sciaccaluga M; Ghiglieri V; Tozzi A; Anceaume E; Cuoc E; Caboche J; Conquet F; Calabresi P; Charvin D
    Neuropharmacology; 2022 Nov; 218():109205. PubMed ID: 35940348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Striatal dysfunction increases basal ganglia output during motor cortex activation in parkinsonian rats.
    Belluscio MA; Riquelme LA; Murer MG
    Eur J Neurosci; 2007 May; 25(9):2791-804. PubMed ID: 17561844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in dendritic morphology of the prefrontal cortical and striatum neurons in the unilateral 6-OHDA-rat model of Parkinson's disease.
    Solis O; Limón DI; Flores-Hernández J; Flores G
    Synapse; 2007 Jun; 61(6):450-8. PubMed ID: 17372982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exercise attenuates levodopa-induced dyskinesia in 6-hydroxydopamine-lesioned mice.
    Aguiar AS; Moreira EL; Hoeller AA; Oliveira PA; Córdova FM; Glaser V; Walz R; Cunha RA; Leal RB; Latini A; Prediger RD
    Neuroscience; 2013 Jul; 243():46-53. PubMed ID: 23558088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maladaptive Synaptic Plasticity in L-DOPA-Induced Dyskinesia.
    Wang Q; Zhang W
    Front Neural Circuits; 2016; 10():105. PubMed ID: 28066191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quinpirole inhibits levodopa-induced dyskinesias at structural and behavioral levels: Efficacy negated by co-administration of isradipine.
    Collier TJ; Begg L; Stancati JA; Mercado NM; Sellnow RC; Sandoval IM; Sortwell CE; Steece-Collier K
    Exp Neurol; 2023 Nov; 369():114522. PubMed ID: 37640098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-Hydroxy-tryptophan for the treatment of L-DOPA-induced dyskinesia in the rat Parkinson's disease model.
    Tronci E; Lisci C; Stancampiano R; Fidalgo C; Collu M; Devoto P; Carta M
    Neurobiol Dis; 2013 Dec; 60():108-14. PubMed ID: 24004632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. L-DOPA Oppositely Regulates Synaptic Strength and Spine Morphology in D1 and D2 Striatal Projection Neurons in Dyskinesia.
    Suarez LM; Solis O; Aguado C; Lujan R; Moratalla R
    Cereb Cortex; 2016 Oct; 26(11):4253-4264. PubMed ID: 27613437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gypenosides attenuate the development of L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Shin KS; Zhao TT; Park KH; Park HJ; Hwang BY; Lee CK; Lee MK
    BMC Neurosci; 2015 Apr; 16():23. PubMed ID: 25896846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zooming in on the small: the plasticity of striatal dendritic spines in L-DOPA-induced dyskinesia.
    Fieblinger T; Cenci MA
    Mov Disord; 2015 Apr; 30(4):484-93. PubMed ID: 25759263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. L-DOPA-induced dyskinesia in a rat model of Parkinson's disease is associated with the fluctuational release of norepinephrine in the sensorimotor striatum.
    Wang Y; Wang HS; Wang T; Huang C; Liu J
    J Neurosci Res; 2014 Dec; 92(12):1733-45. PubMed ID: 24975553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation.
    Picconi B; Paillé V; Ghiglieri V; Bagetta V; Barone I; Lindgren HS; Bernardi G; Angela Cenci M; Calabresi P
    Neurobiol Dis; 2008 Feb; 29(2):327-35. PubMed ID: 17997101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optostimulation of striatonigral terminals in substantia nigra induces dyskinesia that increases after L-DOPA in a mouse model of Parkinson's disease.
    Keifman E; Ruiz-DeDiego I; Pafundo DE; Paz RM; Solís O; Murer MG; Moratalla R
    Br J Pharmacol; 2019 Jul; 176(13):2146-2161. PubMed ID: 30895594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebellar sensory processing alterations impact motor cortical plasticity in Parkinson's disease: clues from dyskinetic patients.
    Kishore A; Popa T; Balachandran A; Chandran S; Pradeep S; Backer F; Krishnan S; Meunier S
    Cereb Cortex; 2014 Aug; 24(8):2055-67. PubMed ID: 23535177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of striatal L-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats.
    Carta M; Lindgren HS; Lundblad M; Stancampiano R; Fadda F; Cenci MA
    J Neurochem; 2006 Mar; 96(6):1718-27. PubMed ID: 16539687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease.
    Visanji NP; Fox SH; Johnston T; Reyes G; Millan MJ; Brotchie JM
    Neurobiol Dis; 2009 Aug; 35(2):184-92. PubMed ID: 19118628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-homogeneous effect of levodopa on inhibitory circuits in Parkinson's disease and dyskinesia.
    Barbin L; Leux C; Sauleau P; Meyniel C; Nguyen JM; Pereon Y; Damier P
    Parkinsonism Relat Disord; 2013 Feb; 19(2):165-70. PubMed ID: 23000298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Subpopulation of Striatal Neurons Mediates Levodopa-Induced Dyskinesia.
    Girasole AE; Lum MY; Nathaniel D; Bair-Marshall CJ; Guenthner CJ; Luo L; Kreitzer AC; Nelson AB
    Neuron; 2018 Feb; 97(4):787-795.e6. PubMed ID: 29398356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.